Emc Capital Management Crispr Therapeutics Ag Transaction History
Emc Capital Management
- $152 Million
- Q3 2024
A detailed history of Emc Capital Management transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Emc Capital Management holds 3,330 shares of CRSP stock, worth $132,167. This represents 0.14% of its overall portfolio holdings.
Number of Shares
3,330
Previous 9,300
64.19%
Holding current value
$132,167
Previous $496,000
56.45%
% of portfolio
0.14%
Previous 0.29%
Shares
3 transactions
Others Institutions Holding CRSP
# of Institutions
489Shares Held
57.9MCall Options Held
1.1MPut Options Held
1.9M-
Capital International Investors Los Angeles, CA7.93MShares$315 Million0.07% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$298 Million3.35% of portfolio
-
State Street Corp Boston, MA2.99MShares$119 Million0.01% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.97MShares$118 Million0.1% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$118 Million1.61% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.1B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....